Mesenchymal Stem Cell Exosomes Promote Functional Osteochondral Repair in a Clinically Relevant Porcine Model

Background: Previous studies have reported the efficacy of human mesenchymal stem cell (MSC) exosomes for the repair of osteochondral defects in rats and rabbits. However, the safety and efficacy of MSC exosomes remain to be validated in a clinically relevant large animal model. Purpose: To validate the safety and efficacy of human MSC exosomes for osteochondral repair in a clinically relevant micropig model. Study Design: Controlled laboratory study. Methods: Bilateral osteochondral defects (6-mm diameter and 1-mm depth) were surgically created in the medial femoral condyles in knees of 12 micropigs. The pigs then received 2-mL intra-articular injections of MSC exosomes and hyaluronic acid (HA) (Exosome+HA) or HA alone after surgery and thereafter at 8 and 15 days. Osteochondral repair was assessed by magnetic resonance imaging (MRI) at 15 days and at 2 and 4 months after surgery as well as by macroscopic, histological, biomechanical, and micro—computed tomography (micro-CT) analyses at 4 months after surgery. Results: Exosome+HA–treated defects demonstrated significantly better MRI scores than HA-treated defects at 15 days and at 2 and 4 months. Additionally, Exosome+HA–treated defects demonstrated functional cartilage and subchondral bone repair, with significantly better macroscopic and histological scores and biomechanical properties (Young modulus and stiffness) than HA-treated defects at 4 months. Micro-CT further showed significantly higher bone volume and trabecular thickness in the subchondral bone of Exosome+HA–treated defects than that of HA-treated defects. Importantly, no adverse response or major systemic alteration was observed in any of the animals. Conclusion: This study shows that the combination of MSC exosomes and HA administered at a clinically acceptable frequency of 3 weekly intra-articular injections can promote functional cartilage and subchondral bone repair, with significantly improved morphological, histological, and biomechanical outcomes in a clinically relevant porcine model. Clinical Relevance: Our findings provide a robust scientific rationale to support a phase 1/2 clinical trial to test MSC exosomes in patients with osteochondral lesions.

[1]  S. Lim,et al.  Mesenchymal Stem Cell Extracellular Vesicles as Adjuvant to Bone Marrow Stimulation in Chondral Defect Repair in a Minipig Model , 2021, Cartilage.

[2]  M. Brizzi,et al.  Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. , 2021, Cytotherapy.

[3]  Chuan Ye,et al.  Intra-articular platelet-rich plasma combined with hyaluronic acid injection for knee osteoarthritis is superior to PRP or HA alone in inhibiting inflammation and improving pain and function. , 2020, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[4]  S. Lim,et al.  Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome , 2020, Stem Cell Research & Therapy.

[5]  Keng Lin Wong,et al.  Intra-articular injections of mesenchymal stem cell exosomes and hyaluronic acid improve structural and mechanical properties of repaired cartilage in a rabbit model. , 2020, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[6]  K. Freedman,et al.  Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial , 2020, The American journal of sports medicine.

[7]  K. L. Wong,et al.  Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee , 2019, The American journal of sports medicine.

[8]  A. Hill,et al.  Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications , 2019, Journal of extracellular vesicles.

[9]  S. Fan,et al.  Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration , 2019, Theranostics.

[10]  Liu Yang,et al.  miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. , 2019, Biomaterials.

[11]  S. Lim,et al.  MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. , 2019, Biomaterials.

[12]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[13]  S. Lim,et al.  Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. , 2018, Cytotherapy.

[14]  S. Lim,et al.  MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. , 2018, Biomaterials.

[15]  C. Jorgensen,et al.  Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis , 2017, Scientific Reports.

[16]  H. Ouyang,et al.  Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix , 2017, Stem Cell Research & Therapy.

[17]  S. Lim,et al.  MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. , 2017, Seminars in cell & developmental biology.

[18]  W. Toh,et al.  Distribution of pericellular matrix molecules in the temporomandibular joint and their chondroprotective effects against inflammation , 2017, International Journal of Oral Science.

[19]  Chang-Qing Zhang,et al.  Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model , 2017, Theranostics.

[20]  S. Lim,et al.  Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. , 2016, Osteoarthritis and cartilage.

[21]  S. Lim,et al.  Mesenchymal stem cell exosomes. , 2015, Seminars in cell & developmental biology.

[22]  S. Lim,et al.  Mesenchymal stem cells secrete immunologically active exosomes. , 2014, Stem cells and development.

[23]  K. L. Wong,et al.  Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up. , 2013, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[24]  Gerard Pasterkamp,et al.  Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. , 2013, Stem cell research.

[25]  Chung-Gyu Park,et al.  Analysis of reference interval and age-related changes in serum biochemistry and hematology in the specific pathogen free miniature pig , 2012, Laboratory animal research.

[26]  S. Lim,et al.  Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs , 2011, Journal of Translational Medicine.

[27]  H. Nejadnik,et al.  Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation , 2010, The American journal of sports medicine.

[28]  Gerard Pasterkamp,et al.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.

[29]  R. Kandel,et al.  A New Histology Scoring System for the Assessment of the Quality of Human Cartilage Repair: ICRS II , 2010, The American journal of sports medicine.

[30]  M. Szczodry,et al.  Animal models for cartilage regeneration and repair. , 2010, Tissue engineering. Part B, Reviews.

[31]  M. Amling,et al.  Long term results after implantation of tissue engineered cartilage for the treatment of osteochondral lesions in a minipig model , 2008, Journal of materials science. Materials in medicine.

[32]  Hui Zhao,et al.  Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells*S , 2007, Molecular & Cellular Proteomics.

[33]  G. Knutsen,et al.  Arthroscopic assessment of cartilage repair: a validation study of 2 scoring systems. , 2005, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[34]  Herwig Imhof,et al.  Definition of pertinent parameters for the evaluation of articular cartilage repair tissue with high-resolution magnetic resonance imaging. , 2004, European journal of radiology.

[35]  Prof A. Bryson.  Appendixes , 2003 .

[36]  E B Hunziker,et al.  Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. , 2002, Osteoarthritis and cartilage.

[37]  C B Sledge,et al.  Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. , 1998, Biomaterials.

[38]  J. Lumsden.  Clinical Biochemistry of Domestic Animals. , 1998 .

[39]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[40]  Jerry C. Hu,et al.  Repair and tissue engineering techniques for articular cartilage , 2015, Nature Reviews Rheumatology.

[41]  E. Pei,et al.  Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation An Observational Cohort Study , 2010 .